KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)R&D In ProcessShares OutstandingShort-Term Debt issuances
Ratios

Bristol Myers Squibb (BMY) Leases (2019 - 2025)

Historic Leases for Bristol Myers Squibb (BMY) over the last 7 years, with Q3 2025 value amounting to $1.6 billion.

  • Bristol Myers Squibb's Leases rose 1899.11% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 1899.11%. This contributed to the annual value of $1.2 billion for FY2024, which is 1194.24% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Leases stood at $1.6 billion for Q3 2025, which was up 1899.11% from $1.3 billion recorded in Q2 2025.
  • Bristol Myers Squibb's Leases' 5-year high stood at $1.6 billion during Q3 2025, with a 5-year trough of $840.0 million in Q2 2022.
  • In the last 5 years, Bristol Myers Squibb's Leases had a median value of $1.2 billion in 2024 and averaged $1.2 billion.
  • Per our database at Business Quant, Bristol Myers Squibb's Leases plummeted by 1650.1% in 2022 and then surged by 5481.31% in 2023.
  • Over the past 5 years, Bristol Myers Squibb's Leases (Quarter) stood at $919.0 million in 2021, then skyrocketed by 32.75% to $1.2 billion in 2022, then rose by 13.93% to $1.4 billion in 2023, then decreased by 11.94% to $1.2 billion in 2024, then soared by 31.05% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.2 billion during Q1 2025.